Sana Biotechnology Inc (SANA)
3.74
+0.08
(+2.19%)
USD |
NASDAQ |
Nov 04, 16:00
3.69
-0.05
(-1.34%)
Pre-Market: 08:39
Sana Biotechnology Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Foghorn Therapeutics Inc | 0.00 |
| Omega Therapeutics Inc | 0.6439 |
| Moderna Inc | 0.00 |
| Summit Therapeutics Inc | -- |
| Apellis Pharmaceuticals Inc | 1.730 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 618.67M |
| Total Liabilities (Quarterly) | 279.02M |
| Shareholders Equity (Quarterly) | 339.65M |